scispace - formally typeset
M

Mario Ermani

Researcher at University of Padua

Publications -  226
Citations -  10294

Mario Ermani is an academic researcher from University of Padua. The author has contributed to research in topics: Temozolomide & Population. The author has an hindex of 51, co-authored 225 publications receiving 9329 citations.

Papers
More filters
Journal ArticleDOI

Prevalence and Characteristics of the Metabolic Syndrome in Primary Aldosteronism

TL;DR: A negative effect of aldosterone excess on glucose metabolism is confirmed and the recently reported higher rates of cardiovascular events in primary aldosteronism than in essential hypertension might be due to increased prevalence of the metabolic syndrome in the former condition.
Journal ArticleDOI

Effects of Fluoxetine and Maprotiline on Functional Recovery in Poststroke Hemiplegic Patients Undergoing Rehabilitation Therapy

TL;DR: The effects of fluoxetine as an adjunct to physical therapy warrant further investigation, since treatment with fluoxettine may result in a better functional outcome from stroke than physical therapy alone.
Journal ArticleDOI

Recurrence Pattern After Temozolomide Concomitant With and Adjuvant to Radiotherapy in Newly Diagnosed Patients With Glioblastoma: Correlation With MGMT Promoter Methylation Status

TL;DR: After the administration of TMZ concomitant with and adjuvant to RT in patients with GBM, the pattern of, and time to, recurrence are strictly correlated with MGMT methylation status.
Journal ArticleDOI

Transcranial magnetic stimulation of dorsolateral prefrontal cortex reduces cocaine use: A pilot study

TL;DR: The present preliminary findings support the safety of rTMS in cocaine-addicted patients, and suggest its potential therapeutic role for rT MS-driven PFC stimulation in reducing cocaine use, providing a strong rationale for developing larger placebo-controlled studies.